0001104659-23-005475.txt : 20230120
0001104659-23-005475.hdr.sgml : 20230120
20230120173735
ACCESSION NUMBER: 0001104659-23-005475
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230118
FILED AS OF DATE: 20230120
DATE AS OF CHANGE: 20230120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bruck Claudine
CENTRAL INDEX KEY: 0001733680
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39202
FILM NUMBER: 23542058
MAIL ADDRESS:
STREET 1: 4995 BRADENTON AVE, SUITE 240
CITY: DUBLIN
STATE: OH
ZIP: 43017-3552
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Annovis Bio, Inc.
CENTRAL INDEX KEY: 0001477845
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262540421
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1055 WESTLAKES DRIVE, SUITE 300
CITY: BERWYN
STATE: PA
ZIP: 19312
BUSINESS PHONE: 610-727-3913
MAIL ADDRESS:
STREET 1: 1055 WESTLAKES DRIVE, SUITE 300
CITY: BERWYN
STATE: PA
ZIP: 19312
FORMER COMPANY:
FORMER CONFORMED NAME: QR Pharma, Inc.
DATE OF NAME CHANGE: 20091202
4
1
tm234043-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2023-01-18
0
0001477845
Annovis Bio, Inc.
ANVS
0001733680
Bruck Claudine
C/O ANNOVIS BIO, INC.
1055 WESTLAKES DRIVE, SUITE 300
BERWYN
PA
19312
1
0
0
0
Stock Option (right to buy)
13.17
2023-01-18
4
A
0
5967
0
A
2033-01-18
Common Stock
5967
5967
D
The stock option shall vest in eight consecutive equal quarterly installments each on the 18th day of April, July, October and January of each year, commencing April 18, 2023, and continuing through January 18, 2025.
/s/ Henry Hagopian, III, Attorney-in-Fact for Claudine Bruck
2023-01-20